| Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD |
| Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015 |
| Abstract : |
| PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| PubMedID: 25973909 |
| Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD |
| Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015 |
| Abstract : |
| PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| PubMedID: 25973909 |
| Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD |
| Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015 |
| Abstract : |
| PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192 |
| PubMedID: 25973909 |
| Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD |
| Ref : Psychopharmacology (Berl) , 219 :715 , 2012 |
| Abstract : |
| PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| PubMedID: 21748252 |
| Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD |
| Ref : Psychopharmacology (Berl) , 219 :715 , 2012 |
| Abstract : |
| PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| PubMedID: 21748252 |
| Title : Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study - Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| Author(s) : Apostol G , Abi-Saab WM , Kratochvil CJ , Adler LA , Robieson WZ , Gault LM , Pritchett YL , Feifel D , Collins MA , Saltarelli MD |
| Ref : Psychopharmacology (Berl) , 219 :715 , 2012 |
| Abstract : |
| PubMedSearch : Apostol_2012_Psychopharmacology.(Berl)_219_715 |
| PubMedID: 21748252 |